{"log_id": 314672234352014816, "direction": 0, "words_result_num": 55, "words_result": [{"probability": {"variance": 2.1e-05, "average": 0.997861, "min": 0.970685}, "location": {"width": 880, "top": 153, "height": 53, "left": 196}, "words": "加巴喷丁很少代谢,也不干扰其他一般合用的抗癫痫药物的代谢。这部分描述的药物相互作用数据是从相关健"}, {"probability": {"variance": 0.000333, "average": 0.99178, "min": 0.926046}, "location": {"width": 294, "top": 203, "height": 35, "left": 152}, "words": "康成人和癫痫症患者的研究中得到的"}, {"probability": {"variance": 0.00304, "average": 0.980164, "min": 0.714986}, "location": {"width": 878, "top": 212, "height": 54, "left": 199}, "words": "苯妥英:已服用苯妥英治疗维持至少二个月的癫痫患者(N=8)进行加巴喷丁(每次0.4g,每日三次)单次"}, {"probability": {"variance": 3.6e-05, "average": 0.997429, "min": 0.966607}, "location": {"width": 923, "top": 241, "height": 58, "left": 154}, "words": "和多次给药的研究,结果表明加巴喷丁对苯妥英的稳态血浆浓度没有影响,并且苯妥英对加巴喷丁的药代动力学也"}, {"probability": {"variance": 0.002146, "average": 0.984241, "min": 0.778691}, "location": {"width": 877, "top": 302, "height": 55, "left": 201}, "words": "卡巴咪嗪服用加巴喷丁(每次0.4g,每日三次:N=12)不影响卡巴咪嗪和卡巴咪嗪10,11环氧化物的稳态血"}, {"probability": {"variance": 0, "average": 0.999493, "min": 0.998767}, "location": {"width": 79, "top": 304, "height": 23, "left": 154}, "words": "没有影响"}, {"probability": {"variance": 8.8e-05, "average": 0.995111, "min": 0.961036}, "location": {"width": 535, "top": 343, "height": 47, "left": 156}, "words": "浆浓度。同样地,服用卡巴咪嗪也不会改变加巴喷丁的药代动力学"}, {"probability": {"variance": 0.005567, "average": 0.980829, "min": 0.512499}, "location": {"width": 879, "top": 362, "height": 54, "left": 202}, "words": "丙戊酸在同时服用加巴喷丁(每次0.4g,每日三次;N=17)前和服用期间,丙戊酸平均稳态血浆浓度无差"}, {"probability": {"variance": 1.1e-05, "average": 0.998205, "min": 0.984672}, "location": {"width": 423, "top": 407, "height": 41, "left": 158}, "words": "异,加巴喷丁的药代动力学数据也不受丙戊酸的影响"}, {"probability": {"variance": 0.000284, "average": 0.993687, "min": 0.886316}, "location": {"width": 878, "top": 420, "height": 55, "left": 205}, "words": "镇静安眠剂不管是单独服用还是联合用药,镇静安眠剂或加巴喷丁(每次0.3g,每日三次;N=12)稳态药代"}, {"probability": {"variance": 0, "average": 0.999459, "min": 0.998664}, "location": {"width": 204, "top": 474, "height": 33, "left": 159}, "words": "动力学数据评估是一样的"}, {"probability": {"variance": 0.00061, "average": 0.988828, "min": 0.882011}, "location": {"width": 358, "top": 497, "height": 37, "left": 206}, "words": "萘普生同时使用萘普生钠胶囊(250mg)和"}, {"probability": {"variance": 0.000128, "average": 0.995128, "min": 0.951848}, "location": {"width": 342, "top": 480, "height": 36, "left": 742}, "words": "加巴喷丁的吸收增加12%到15%。加巴喷丁"}, {"probability": {"variance": 0.002273, "average": 0.98386, "min": 0.737415}, "location": {"width": 922, "top": 509, "height": 54, "left": 162}, "words": "对萘普生的药代动力学参数没有影响。两者所给的剂量均低于各自的治疗剂量。在推荐剂量范围时其相互作用情况"}, {"probability": {"variance": 1e-06, "average": 0.999161, "min": 0.997287}, "location": {"width": 74, "top": 567, "height": 23, "left": 164}, "words": "尚不清楚"}, {"probability": {"variance": 0.009591, "average": 0.953095, "min": 0.501965}, "location": {"width": 703, "top": 572, "height": 47, "left": 209}, "words": "二氢可待因酮合用加巴喷丁(0.125至0.5g;N=48)后二氢可待因酮<10mg,N=50)的"}, {"probability": {"variance": 0.026277, "average": 0.933638, "min": 0.505471}, "location": {"width": 129, "top": 570, "height": 22, "left": 957}, "words": "和AUC降低,与"}, {"probability": {"variance": 0.004324, "average": 0.971193, "min": 0.704431}, "location": {"width": 413, "top": 611, "height": 39, "left": 171}, "words": "所给二氢可待因酮的剂量呈依赖关系。合用加巴喷丁"}, {"probability": {"variance": 0.00357, "average": 0.975962, "min": 0.672517}, "location": {"width": 462, "top": 596, "height": 39, "left": 625}, "words": "25g)使二氢可待因酮(10mg,N=50)的Cmax和AUC降低"}, {"probability": {"variance": 0.006834, "average": 0.955235, "min": 0.682973}, "location": {"width": 412, "top": 640, "height": 38, "left": 164}, "words": "约3%~4%,合用加巴喷丁(0,5g)使二氢可待因酮"}, {"probability": {"variance": 1.2e-05, "average": 0.991352, "min": 0.988371}, "location": {"width": 53, "top": 636, "height": 21, "left": 671}, "words": "50)的"}, {"probability": {"variance": 0.002204, "average": 0.976461, "min": 0.824834}, "location": {"width": 296, "top": 627, "height": 28, "left": 792}, "words": "AC降低约21%~22%。这种相互作用"}, {"probability": {"variance": 0.002282, "average": 0.984986, "min": 0.694447}, "location": {"width": 766, "top": 657, "height": 50, "left": 165}, "words": "机制尚不明确二氢可待因酮能增加加巴喷丁的AUC约14%。其他剂量的相互作用情况还不明确"}, {"probability": {"variance": 0.001127, "average": 0.984674, "min": 0.803443}, "location": {"width": 876, "top": 681, "height": 52, "left": 215}, "words": "吗啡据文献报道,给予60mg控释吗啡胶囊2小时后再给予0.6g加巴喷丁胶囊(N=12),加巴喷丁的平均AUC"}, {"probability": {"variance": 0.010517, "average": 0.972332, "min": 0.420781}, "location": {"width": 922, "top": 710, "height": 53, "left": 168}, "words": "比未用吗啡时增加了44%(见警告)。服用加巴喷丁后吗啡的药代动力学参数没有变化与其它剂量的相互作用尚不"}, {"probability": {"variance": 1e-06, "average": 0.998864, "min": 0.997763}, "location": {"width": 39, "top": 769, "height": 21, "left": 168}, "words": "清楚"}, {"probability": {"variance": 0.003471, "average": 0.977366, "min": 0.660935}, "location": {"width": 877, "top": 766, "height": 52, "left": 213}, "words": "甲氰咪胍服用甲氰咪胍每次0.3g,每日4次(N=12),加巴喷丁平均表观口服清除率下降14%,肌酐清除率下"}, {"probability": {"variance": 0.000505, "average": 0.990121, "min": 0.863955}, "location": {"width": 920, "top": 795, "height": 52, "left": 171}, "words": "降10%。因而,甲氰咪胍可能会改变加巴喷丁肌酐的肾排泄。由甲氰咪胍引起的加巴喷丁排泄的小幅度下降没有重要"}, {"probability": {"variance": 0.001524, "average": 0.983436, "min": 0.832647}, "location": {"width": 396, "top": 838, "height": 39, "left": 177}, "words": "的临床意义。加巴喷丁对甲氰咪胍的影响没有评价"}, {"probability": {"variance": 0.015368, "average": 0.952524, "min": 0.509938}, "location": {"width": 881, "top": 849, "height": 55, "left": 216}, "words": "口服避孕药服用含有2.5mg乙酸炔诺和501g乙炔基雌二醇的药片后,不管是否同时服用加巴喷丁(每次"}, {"probability": {"variance": 0.005193, "average": 0.982177, "min": 0.461878}, "location": {"width": 925, "top": 879, "height": 55, "left": 173}, "words": "04g,每日三次;N=13),乙酸炔诺酮和乙炔基雌二醇的AUC和半衰期是类似的。和加巴喷丁联合给药时,炔诺酮的"}, {"probability": {"variance": 0.000963, "average": 0.987521, "min": 0.850172}, "location": {"width": 392, "top": 923, "height": 41, "left": 172}, "words": "C升高13%;这一相互作用没有重要的临床意义"}, {"probability": {"variance": 0.009788, "average": 0.969566, "min": 0.400833}, "location": {"width": 883, "top": 934, "height": 56, "left": 220}, "words": "抗酸剂(氢氧化铝)氢氧化铝降低加巴喷丁的生物利用变大约20%服用氢氧化铝后2小时服用加巴喷,生"}, {"probability": {"variance": 0.000133, "average": 0.996243, "min": 0.936434}, "location": {"width": 648, "top": 973, "height": 46, "left": 176}, "words": "物利用度下降大约5%。因此,建议加巴喷丁应在氢氧化铝服用后至少2小时服用"}, {"probability": {"variance": 0.003283, "average": 0.983321, "min": 0.6082}, "location": {"width": 878, "top": 993, "height": 54, "left": 222}, "words": "丙磺舒(羧苯磺丙胺)的作用:丙磺舒是一种肾小管分泌阻滞剂。将加巴喷丁结合或不结合丙磺舒试验的药代"}, {"probability": {"variance": 4.5e-05, "average": 0.996715, "min": 0.968791}, "location": {"width": 626, "top": 1031, "height": 45, "left": 177}, "words": "动力学参数进行比较,结果证实加巴喷丁不能流经被丙磺舒阻滞的肾小管路径"}, {"probability": {"variance": 0.000322, "average": 0.987782, "min": 0.953069}, "location": {"width": 104, "top": 1079, "height": 24, "left": 182}, "words": "【药物过量】"}, {"probability": {"variance": 0.0031, "average": 0.987315, "min": 0.6283}, "location": {"width": 879, "top": 1079, "height": 53, "left": 222}, "words": "据报道,在服用加巴喷丁过量达49克的患者中,可出现复视、口齿不清、嗜睡、淡漠和腹泻。所有患者经抢"}, {"probability": {"variance": 4.7e-05, "average": 0.997376, "min": 0.964376}, "location": {"width": 879, "top": 1136, "height": 52, "left": 226}, "words": "加巴喷丁可通过血液透析清除。尽管在本品过量的患者尚未进行血液透析,但在一些肾功能损害患者体内可被"}, {"probability": {"variance": 0, "average": 0.999545, "min": 0.998749}, "location": {"width": 76, "top": 1138, "height": 22, "left": 180}, "words": "救后康复"}, {"probability": {"variance": 0.000431, "average": 0.991383, "min": 0.936454}, "location": {"width": 146, "top": 1191, "height": 28, "left": 185}, "words": "观察到其清除过程"}, {"probability": {"variance": 2e-06, "average": 0.99925, "min": 0.99652}, "location": {"width": 100, "top": 1223, "height": 22, "left": 188}, "words": "【药理毒理】"}, {"probability": {"variance": 0.000839, "average": 0.98047, "min": 0.930598}, "location": {"width": 76, "top": 1251, "height": 22, "left": 229}, "words": "药理作用"}, {"probability": {"variance": 0.003583, "average": 0.979539, "min": 0.705027}, "location": {"width": 888, "top": 1253, "height": 53, "left": 219}, "words": "加巴喷丁抗惊厥作用的机制尚不明确,但动物试验提示,与其他上市的抗惊厥药物相似,加巴喷丁可抑制癫痫"}, {"probability": {"variance": 0.004582, "average": 0.98472, "min": 0.528663}, "location": {"width": 923, "top": 1280, "height": 54, "left": 184}, "words": "发作。小鼠和大鼠最大电休克试验、苯四唑癫痫发作试验以及其他动物试验(如遗传性癲痫模型等)结果提示,加"}, {"probability": {"variance": 0.004202, "average": 0.985077, "min": 0.642859}, "location": {"width": 534, "top": 1319, "height": 45, "left": 186}, "words": "巴喷丁具有抗癫痫作用,但这些癫痫模型与人体的相关性尚不清楚"}, {"probability": {"variance": 2.3e-05, "average": 0.997564, "min": 0.975154}, "location": {"width": 885, "top": 1338, "height": 54, "left": 222}, "words": "加巴喷丁在结构上与神经递质GABA相关,但不与GABA受体产生相互作用,它既不能代谢转化为GABA或GABA"}, {"probability": {"variance": 0.003466, "average": 0.987085, "min": 0.576633}, "location": {"width": 924, "top": 1366, "height": 54, "left": 187}, "words": "激动剂,也不是GABA摄取或降解的抑制剂。放射性配体结合试验发现,加巴喷丁浓度达到100μM时,对许多常见"}, {"probability": {"variance": 0.006209, "average": 0.977265, "min": 0.565271}, "location": {"width": 520, "top": 1405, "height": 44, "left": 187}, "words": "受体位点无亲和力,包括苯二氮卓受体、谷氨酸受体、NMDA受体"}, {"probability": {"variance": 0.020981, "average": 0.956678, "min": 0.399365}, "location": {"width": 285, "top": 1394, "height": 32, "left": 827}, "words": "受体、海人草酸受体、番木鳖碱不"}, {"probability": {"variance": 0.000206, "average": 0.993917, "min": 0.947935}, "location": {"width": 268, "top": 1443, "height": 34, "left": 190}, "words": "敏感性或敏感性的氨基乙酸受体"}, {"probability": {"variance": 0.014346, "average": 0.959133, "min": 0.354575}, "location": {"width": 580, "top": 1422, "height": 42, "left": 532}, "words": "2或B受体、腺苷A或A2受体、M或N受体、多巴胺D1或D2受体、H1"}, {"probability": {"variance": 0.012855, "average": 0.965799, "min": 0.365099}, "location": {"width": 909, "top": 1450, "height": 55, "left": 191}, "words": "受体、5-羟色胺S1或S2受体、阿片μ,或k受体、尼群地平或地尔硫卓标记的电压敏感钙通道位点、蛙毒素A20-"}, {"probability": {"variance": 0.000379, "average": 0.994736, "min": 0.861293}, "location": {"width": 923, "top": 1479, "height": 55, "left": 191}, "words": "苯甲酸盐标记的电压敏感的钠通道位点。由于在评价药物对NMDA受体作用的几个常用试验所得出的结果是相反,故"}, {"probability": {"variance": 0.00565, "average": 0.979792, "min": 0.611343}, "location": {"width": 451, "top": 1524, "height": 41, "left": 192}, "words": "目前尚无任何关于加巴喷丁对NMDA受体作用的统一认识"}], "language": 3}